The Italian Medicines Agency (Agenzia Italiana del Farmaco, AIFA) reports that collectively manufacturers have now paid 87% of the amount due for exceeding the pharmaceutical spending cap for direct purchases in 2019 and 2020.
For the year 2019, 156 companies liable for repayments have collectively paid 92% of the total amount due while for the year 2020, 134 companies have paid 81% of the amount due. Collectively, companies still owe AIFA €370 million of the €2.8 billion that industry has to repay for exceeding the pharmaceutical spending cap for direct purchases in 2019 and 2020.
Source:
www.aifa.gov.it, “Riepilogo dei pagamenti di Ripiano della spesa farmaceutica acquisti diretti anni 2019 e 2020 – Aggiornamento del 17/02/2022”, 17th February 2022